Edwards Lifesciences Corporation Derivative Liability, Current
Edwards Lifesciences Corporation (EW) had Derivative Liability, Current of $6.30 million as of 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:DerivativeLiabilitiesCurrent · last filed 2026-08-04
- 2026-06-30: Derivative Liability, Current $6.30M.
- 2026-03-31: Derivative Liability, Current $7.60M.
- 2025-12-31: Derivative Liability, Current $25.30M.
- 2025-09-30: Derivative Liability, Current $34.50M.
| Period end | Derivative Liability, Current | Derivative Liability, Current as first filed |
|---|---|---|
| 2026-06-30 | $6.30M 10-Q · filed 2026-08-04 | |
| 2026-03-31 | $7.60M 10-Q · filed 2026-05-06 | |
| 2025-12-31 | $25.30M 10-Q · filed 2026-08-04 | |
| 2025-09-30 | $34.50M 10-Q · filed 2025-11-05 | |
| 2025-06-30 | $54.20M 10-Q · filed 2025-08-06 | |
| 2025-03-31 | $10.50M 10-Q · filed 2025-05-06 | |
| 2024-12-31 | $8.30M 10-K · filed 2026-02-25 | |
| 2024-09-30 | $24.30M 10-Q · filed 2024-11-06 | |
| 2024-06-30 | $4.70M 10-Q · filed 2024-07-31 | |
| 2024-03-31 | $4.90M 10-Q · filed 2024-04-29 | |
| 2023-12-31 | $15.20M 10-K · filed 2025-02-28 | |
| 2023-09-30 | $6.70M 10-Q · filed 2023-10-27 | |
| 2023-06-30 | $17.80M 10-Q · filed 2023-07-28 | |
| 2023-03-31 | $23.40M 10-Q · filed 2023-04-28 | |
| 2022-12-31 | $20.70M 10-K · filed 2024-02-12 | |
| 2022-09-30 | $4.40M 10-Q · filed 2022-10-28 | |
| 2022-06-30 | $2.00M 10-Q · filed 2022-07-29 | |
| 2022-03-31 | $3.80M 10-Q · filed 2022-04-28 | |
| 2021-12-31 | $3.90M 10-K · filed 2023-02-13 | |
| 2021-09-30 | $3.50M 10-Q · filed 2021-10-29 | |
| 2021-06-30 | $7.90M 10-Q · filed 2021-07-30 | |
| 2021-03-31 | $16.10M 10-Q · filed 2021-04-28 | |
| 2020-12-31 | $39.30M 10-K · filed 2022-02-14 | |
| 2020-09-30 | $21.40M 10-Q · filed 2020-10-26 | |
| 2020-06-30 | $6.40M 10-Q · filed 2020-07-27 | |
| 2020-03-31 | $6.60M 10-Q · filed 2020-04-28 | |
| 2019-12-31 | $6.40M 10-K · filed 2021-02-12 | |
| 2019-09-30 | $4.50M 10-Q · filed 2019-10-25 | |
| 2019-06-30 | $4.60M 10-Q · filed 2019-07-26 | |
| 2019-03-31 | $4.00M 10-Q · filed 2019-04-26 | |
| 2018-12-31 | $4.40M 10-K · filed 2020-02-14 | |
| 2018-09-30 | $3.30M 10-Q · filed 2018-10-26 | |
| 2018-06-30 | $5.30M 10-Q · filed 2018-07-27 | |
| 2018-03-31 | $25.90M 10-Q · filed 2018-04-27 | |
| 2017-12-31 | $24.80M 10-K · filed 2019-02-15 | |
| 2017-09-30 | $25.80M 10-Q · filed 2017-10-27 | |
| 2017-06-30 | $15.40M 10-Q · filed 2017-07-28 | |
| 2017-03-31 | $3.60M 10-Q · filed 2017-04-28 | |
| 2016-12-31 | $3.30M 10-K · filed 2018-02-16 | |
| 2016-09-30 | $19.40M 10-Q · filed 2016-10-28 | |
| 2016-06-30 | $24.10M 10-Q · filed 2016-07-29 | |
| 2016-03-31 | $33.30M 10-Q · filed 2016-04-29 | |
| 2015-12-31 | $4.20M 10-K · filed 2017-02-17 | |
| 2015-09-30 | $11.70M 10-Q · filed 2015-10-29 | |
| 2015-06-30 | $5.10M 10-Q · filed 2015-07-29 | |
| 2015-03-31 | $4.60M 10-Q · filed 2015-04-29 | |
| 2014-12-31 | $2.60M 10-K · filed 2016-02-19 | |
| 2014-09-30 | $2.20M 10-Q · filed 2014-10-31 | |
| 2013-12-31 | $13.10M 10-K · filed 2015-02-20 | $17.20M 10-K · filed 2014-02-28 |
| 2010-12-31 | $14.70M 10-K · filed 2012-02-27 | |
| 2009-12-31 | $3.00M 10-K · filed 2011-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STERIS plc (STE) | Ireland | $20.343B | 25.49 |
| ZIMMER BIOMET HOLDINGS, INC. (ZBH) | United States | $17.103B | 20.66 |
| ALIGN TECHNOLOGY INC (ALGN) | United States | $10.346B | 29.06 |
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |